Long-acting antipsychotic (unspecified)

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Long-acting antipsychotic (unspecified), covering 2011-06-08 to 2011-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia [Phase 3]